{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:32:46Z","timestamp":1782603166749,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mirror syndrome (MS) is a rare obstetric disorder complicated with high maternal morbidity and fetal mortality. MS is often misdiagnosed or underdiagnosed due to the low incidence and lack of awareness of its diverse features. This study aimed to summarise the etiology, clinical characteristics, and risk factors of MS among mothers with fetal hydrops.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective case-control study included 37 pregnant women with fetal hydrops in the second and third trimesters from 58,428 deliveries performed at the Third Affiliated Hospital of Sun Yat-Sen University between January 2012 and December 2020. Cases were categorized as MS and non-MS according to the presence or absence of maternal mirroring symptoms. Binary logistic regression was performed for analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fourteen women developed MS with an overall incidence of 0.024% (14\/58,428) and 37.8% (14\/37) in the fetal hydrops cases. Among the 11 MS cases with known associated etiologies, seven had alpha thalassemia major. Onset of fetal hydrops was later (27.8 vs. 23.0\u2009weeks) and the rate of placental thickening was higher (85.7% vs. 34.8%) in the MS group than in the non-MS group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Regarding maternal characteristics, the MS group had higher maternal morbidity (85.7% vs. 8.7%), more weight gain (9.0 vs. 5.5\u2009kg), higher rates of hypertension (35.7 vs. 0%) and proteinuria (64.3% vs. 4.3%), and lower levels of hemoglobin (88 vs. 105\u2009g\/L) and serum albumin (25.8 vs. 35.0\u2009g\/L) than the non-MS group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Logistic regression analysis showed that onset of fetal hydrops at \u226524\u2009weeks and placental thickening were associated with the risk of MS among fetal hydrops cases (OR 15.83, 95% CI 1.56\u2013160.10 and OR 8.63, 95% CI 1.29\u201357.72, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MS is relatively common among fetal hydrops cases in the late second and third trimesters, and alpha thalassemia major is the main etiology for fetal hydrops and also MS in this population. Complicated with high maternal morbidity, the key maternal features of MS include more weight gain, hemodilution, and hypertension. Among those with fetal hydrops, the onset time of \u226524\u2009weeks and placental thickening are risk factors for MS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-04143-3","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T15:59:14Z","timestamp":1632844754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical characteristics and risk factors of mirror syndrome: a retrospective case-control study"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhenyan","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"4143_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0002-9378(71)90226-2","volume":"110","author":"IH Kaiser","year":"1971","unstructured":"Kaiser IH. Ballantyne and triple edema. Am J Obstet Gynecol. 1971;110:115\u201320.","journal-title":"Am J Obstet Gynecol"},{"key":"4143_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000305096","volume":"27","author":"T Braun","year":"2010","unstructured":"Braun T, Brauer M, Fuchs I, Czernik C, Dudenhausen JW, Henrich W, et al. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther. 2010;27:191\u2013203.","journal-title":"Fetal Diagn Ther"},{"key":"4143_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1515\/jpm-2016-0422","volume":"45","author":"S Allarakia","year":"2017","unstructured":"Allarakia S, Khayat HA, Karami MM, Aldakhil AM, Kashi AM, Algain AH, et al. Characteristics and management of mirror syndrome: a systematic review (1956-2016). J Perinat Med. 2017;45:1013\u201321.","journal-title":"J Perinat Med"},{"key":"4143_CR4","doi-asserted-by":"publisher","unstructured":"Teles Abrao Trad A, Czeresnia R, Elrefaei A, Ibirogba ER, Narang K, Ruano R. What do we know about the diagnosis and management of mirror syndrome? J Matern Fetal Neonatal Med. 2021;1-6. https:\/\/doi.org\/10.1080\/14767058.2020.1844656. Epub ahead of print.","DOI":"10.1080\/14767058.2020.1844656"},{"key":"4143_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/14767050600922677","volume":"19","author":"J Espinoza","year":"2006","unstructured":"Espinoza J, Romero R, Nien JK, Kusanovic JP, Richani K, Gomez R, et al. A role of the anti-angiogenic factor sVEGFR-1 in the 'mirror syndrome' (Ballantyne's syndrome). J Matern Fetal Neonatal Med. 2006;19:607\u201313.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4143_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejogrb.2011.04.049","volume":"158","author":"L De Oliveira","year":"2011","unstructured":"De Oliveira L, Sass N, Boute T, Moron AF. sFlt-1 and PlGF levels in a patient with mirror syndrome related to cytomegalovirus infection. Eur J Obstet Gynecol Reprod Biol. 2011;158:366\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4143_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/uog.10136","volume":"40","author":"E Llurba","year":"2012","unstructured":"Llurba E, Marsal G, Sanchez O, Dominguez C, Alijotas-Reig J, Carreras E, et al. Angiogenic and antiangiogenic factors before and after resolution of maternal mirror syndrome. Ultrasound Obstet Gynecol. 2012;40:367\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4143_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1080\/14767058.2018.1500550","volume":"33","author":"SR Hobson","year":"2020","unstructured":"Hobson SR, Wallace EM, Chan YF, Edwards AG, Teoh MWT, Khaw AP-L. Mirroring preeclampsia: the molecular basis of Ballantyne syndrome. J Matern Fetal Neonatal Med. 2020;33:768\u201373.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4143_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajog.2014.12.018","volume":"212","author":"ME Norton","year":"2015","unstructured":"Society for Maternal-Fetal M, Norton ME, Chauhan SP, Dashe JS. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol. 2015;212:127\u201339.","journal-title":"Am J Obstet Gynecol"},{"key":"4143_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000100796","volume":"22","author":"C Liao","year":"2007","unstructured":"Liao C, Wei J, Li Q, Li J, Li L, Li D. Nonimmune Hydrops Fetalis diagnosed during the second half of pregnancy in southern China. Fetal Diagn Ther. 2007;22:302\u20135.","journal-title":"Fetal Diagn Ther"},{"key":"4143_CR11","doi-asserted-by":"publisher","first-page":"10726","DOI":"10.1038\/s41598-019-47050-6","volume":"9","author":"D Meng","year":"2019","unstructured":"Meng D, Li Q, Hu X, Wang L, Tan S, Su J, et al. Etiology and outcome of non-immune Hydrops Fetalis in southern China: report of 1004 cases. Sci Rep. 2019;9:10726.","journal-title":"Sci Rep"},{"key":"4143_CR12","first-page":"2630","volume":"29","author":"G Hirata","year":"2016","unstructured":"Hirata G, Aoki S, Sakamaki K, Takahashi T, Hirahara F, Ishikawa H. Clinical characteristics of mirror syndrome: a comparison of 10 cases of mirror syndrome with non-mirror syndrome fetal hydrops cases. J Matern Fetal Neonatal Med. 2016;29:2630\u20134.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4143_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01443615.2020.1718621","volume":"41","author":"R Chen","year":"2020","unstructured":"Chen R, Liu M, Yan J, Chen F, Han Q, Zheng L, et al. Clinical characteristics of mirror syndrome: a retrospective study of 16 cases. J Obstet Gynaecol. 2020;41:73\u20136.","journal-title":"J Obstet Gynaecol"},{"key":"4143_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/10641955.2011.638959","volume":"31","author":"K Bixel","year":"2012","unstructured":"Bixel K, Silasi M, Zelop CM, Lim KH, Zsengeller Z, Stillman IE, et al. Placental origins of angiogenic dysfunction in mirror syndrome. Hypertens Pregnancy. 2012;31:211\u20137.","journal-title":"Hypertens Pregnancy"},{"key":"4143_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.placenta.2012.02.016","volume":"33","author":"N Graham","year":"2012","unstructured":"Graham N, Garrod A, Bullen P, Heazell AE. Placental expression of anti-angiogenic proteins in mirror syndrome: a case report. Placenta. 2012;33:528\u201331.","journal-title":"Placenta"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04143-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04143-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04143-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T15:59:18Z","timestamp":1632844758000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04143-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4143"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04143-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Boards of the Third Affiliated Hospital of Sun Yat-sen University and written informed consent was obtained from each participant women. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"660"}}